ArticleMolecular cancer research : MCR2026

ACYP2 Induces Temozolomide Resistance in Glioblastoma by Promoting PARP1-Mediated DNA Damage Repair.

Mengjun Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.